Abstract
Capecitabine is an oral prodrug of 5-fluorouracil used in the treatment of adenocarcinoma of the colon. Neurotoxicity is an infrequently reported toxicity of capecitabine. We report a case of cerebellar ataxia secondary to capecitabine therapy.
MeSH terms
-
Adenocarcinoma / drug therapy
-
Aged
-
Antimetabolites, Antineoplastic / adverse effects*
-
Antimetabolites, Antineoplastic / therapeutic use
-
Capecitabine
-
Cecal Neoplasms / drug therapy
-
Cerebellar Ataxia / chemically induced*
-
Cerebellum / drug effects
-
Deoxycytidine / adverse effects
-
Deoxycytidine / analogs & derivatives*
-
Deoxycytidine / therapeutic use
-
Fluorouracil / analogs & derivatives
-
Humans
-
Male
Substances
-
Antimetabolites, Antineoplastic
-
Deoxycytidine
-
Capecitabine
-
Fluorouracil